Citius pharmaceuticals to feature product candidates including stem-cell therapy for covid-19-related acute respiratory conditions at h.c. wainwright global life sciences conference march 9-10

Cranford, n.j., march 4, 2021 /prnewswire/ -- citius pharmaceuticals, inc. ("citius" or the "company") (nasdaq: ctxr), a specialty pharmaceutical company developing and commercializing critical care drug products, today announced that it will present at the h.c. wainwright global life...
CTXR Ratings Summary
CTXR Quant Ranking